当前位置: 首页 > 期刊 > 《中国保健营养》 > 2013年第5期 > 正文
编号:12711861
糖尿病足患者血清维生素D的相关研究(2)
http://www.100md.com 2013年3月1日 李元宾等
第1页

    参见附件。

     [8]Hayes CE,Nashold FE,Spach KM,et al.(2003)The immuno- logical functions of the vitamin D endocrine system.Cell Mol Biol 49,277–300.

    [9]Mattila C,Knekt P,Mannisto S,et al.(2007)Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes.Diabetes Care 30,2569–2570.

    [10]Michael FH,Neil CB,Heike ABF,et al.(2011)Treatment,and prevention of vitamin D defciency:an Endocrine Society clinical practice guideline.J Clin Endocrinol Metab96,1911–1930.

    [11]Institute of Medicine(2011)Dietary Reference Intakes for Calcium and Vitamin D.Washington,DC:The National Academies Press.

    [12]Van EE,Decallonne B,Bouillon R,et al.(2004)NODbone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D(3).J Steroid Biochem Mol Biol 89–90,457–459.

    [13]Van EE & Mathieu C(2005)Immunoregulation by 1,25-dihydroxyvitamin D3:basic concepts.J Steroid Biochem Mol Biol 97,93–101.

    [14]Liu PT,Stenger S & Tang DH(2007)Cutting edge:vitamin D-mediated human antimicrobial activity againstMycobacterium tuberculosis is dependent on the induction of cathelicidin.J Immunol 179,2060–2063.

您现在查看是摘要介绍页,详见PDF附件